내츄럴엔도텍
168330KOSDAQ56.3 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Naturalendo Tech develops health supplements and cosmeceuticals using natural resources and biotechnology, focusing on anti-aging and health promotion. Through its subsidiary Endoderma, the company researches and produces micro-needle patches based on transdermal drug delivery systems (TDDS). Key products include 'Snut Wonder' for menopausal women and the 'NEEDLY' skincare line, with future goals including global market expansion and enhanced ESG practices.
Number of Employees
83people
Average Salary
49.8M KRW
Score Calculation Basis
Detailed Financial Score
2.5x industry avg (risky)
Well below industry avg
Half of industry avg (excellent)
Avg ▲9.2% (2-year basis)
Avg ▲10.1% (2-year basis)
Avg ROE -15.1% (improving, 3yr)
Detailed News Sentiment
- Positive내츄럴엔도텍 ‘EstroG-100®’, ‘NutraIngredients...
내츄럴엔도텍의 혁신적인 제품 'EstroG-100®'이 글로벌 시상식에서 수상하며 국제적인 인정을 받았고, 국내 런칭 성공으로 긍정적인 시장 반응을 이끌어냈습니다.
- Positive내츄럴엔도텍 ‘백수오등복합추출물(EstroG-100®)’, 최신 임상 ...
내츄럴엔도텍의 EstroG-100® 임상 성과 발표로 갱년기 건강기능식품 시장에서의 긍정적 위치 강화.
Detailed Momentum
52w lower range (25%)
1m +16.89% (strong rise)
Volume dry-up
Detailed Disclosure
- Neutral[기재정정]반기보고서 (2026.06)2026-08-18
- Neutral반기보고서 (2026.06)2026-08-14
